SLC34A3 (Q8N130) variants and mutations
SLC34A3 (also known as Q8N130) is a human protein-coding gene encoding a sodium-dependent phosphate transport protein 2C protein. It reabsorbs phosphate in the renal proximal tubule under hormonal control and is essential for maintaining serum phosphate and bone mineralization. Biallelic or dominant pathogenic variants can cause hereditary hypophosphatemic rickets with hypercalciuria. This analysis covers 1,218 SLC34A3 variants and mutations. Of these, 96% have computational variant effect predictions. Disease context includes hereditary hypophosphatemic rickets with hypercalciuria, hereditary disease, and nephrolithiasis. Example SLC34A3 variants include M1?, M1I, and M1T.
Variant analysis overview
- Gene: SLC34A3
- Protein: Q8N130
- UniProt accession: Q8N130
- Organism: Homo sapiens
- Variants analyzed: 1218
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 1,003 unspecified-consequence records; 84 missense variants; 90 synonymous variants; 20 frameshift variants; 6 splice-region variants; 3 stop-gained variants; 9 in-frame deletions; 3 in-frame insertions
- Prediction scores: 1,169 variants have prediction scores (96% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: hereditary hypophosphatemic rickets with hypercalciuria, hereditary disease, nephrolithiasis, urolithiasis, X-linked hypophosphatemia, hypophosphatemic nephrolithiasis/osteoporosis 1, ureterolithiasis, Hypercalciuria, bladder calculus, kidney disorder, hypotensive disorder, nephrocalcinosis.
Protein structure and variant hotspots
- Protein features: 8 transmembrane segments; 5 post-translational modification sites.
- Structural context: 331 variants have structural context.
- PTM context: 7 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable SLC34A3 variants
Examples include M1?, M1I, M1T, P2L, P2R, P2S, P2P, S3N. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, cosmic curated COSV63187
- M1I (p.Met1Ile), rs369400414, ClinGen CA5364161, ClinVar RCV001306324, ClinVar RCV004746310, Pathogenic/Likely pathogenic, not provided; Autosomal recessive hypophosphatemic bone disease
- M1T (p.Met1Thr), rs748739254, ClinGen CA5364160, ClinVar RCV003877530, ClinVar RCV005040606, Pathogenic/Likely pathogenic, not provided; Autosomal recessive hypophosphatemic bone disease
- P2L (p.Pro2Leu), rs566626846, ClinGen CA5364162, ClinVar RCV002633096, 1000Genomes rs566626846, MetaLR 0.06, MetaSVM -1.02, Uncertain significance, not provided
- P2R (p.Pro2Arg), 1000Genomes rs566626846, ExAC rs566626846, TOPMed rs566626846, gnomAD rs566626846, MetaLR 0.05, MetaSVM -1.06, Uncertain significance, Autosomal recessive hypophosphatemic bone disease
- P2S (p.Pro2Ser), gnomAD 9-137231706-C-T, MetaLR 0.06, MetaSVM -1.00
- P2P (p.Pro2Pro), rs771812828, gnomAD 9-137231708-G-A, CADD 8.05
- S3N (p.Ser3Asn), TOPMed rs1836225446, MetaLR 0.02, MetaSVM -0.98
- S3T (p.Ser3Thr), gnomAD 9-137231710-G-C, MetaLR 0.04, MetaSVM -1.02
- S4C (p.Ser4Cys), NCI-TCGA Cosmic COSV1007, cosmic curated COSV10074, Variant assessed as somatic; moderate impact.
- P6T (p.Pro6Thr), gnomAD 9-137231718-C-A, MetaLR 0.02, MetaSVM -0.98
- P6P (p.Pro6Pro), rs772903522, gnomAD 9-137231720-C-T, CADD 0.26
- G7S (p.Gly7Ser), rs759744880, ClinGen CA5364166, ClinVar RCV002573647, ClinVar RCV005042863, MetaLR 0.05, MetaSVM -1.02, Uncertain significance, not provided; Autosomal recessive hypophosphatemic bone disease
- G7V (p.Gly7Val), NCI-TCGA TCGA novel, MetaLR 0.07, MetaSVM -1.05, Variant assessed as somatic; moderate impact.
- G7G (p.Gly7Gly), gnomAD 9-137231723-C-T, CADD 0.21
- S8N (p.Ser8Asn), cosmic curated COSV63187, Ensembl rs1836226250, MetaLR 0.04, MetaSVM -0.96
- S8C (p.Ser8Cys), gnomAD 9-137231724-A-T, MetaLR 0.04, MetaSVM -1.04
- S8S (p.Ser8Ser), gnomAD 9-137231726-C-T, CADD 3.63
- Q9L (p.Gln9Leu), gnomAD 9-137231728-A-T, MetaLR 0.05, MetaSVM -1.05
- V10I (p.Val10Ile), ExAC rs765381678, gnomAD rs765381678, MetaLR 0.05, MetaSVM -1.02
- V10L (p.Val10Leu), ExAC rs765381678, gnomAD rs765381678, MetaLR 0.05, MetaSVM -1.01
- V10F (p.Val10Phe), gnomAD 9-137231730-G-T, MetaLR 0.07, MetaSVM -1.01
- V10V (p.Val10Val), gnomAD 9-137231732-C-T, CADD 1.72
- P11S (p.Pro11Ser), cosmic curated COSV63188, MetaLR 0.16, MetaSVM -1.01
- H12F (p.His12Phe), gnomAD 9-137231712-T-TCC, CADD 22.40
- H12D (p.His12Asp), gnomAD 9-137231736-C-G, MetaLR 0.03, MetaSVM -0.98
- H12Q (p.His12Gln), gnomAD 9-137231738-C-A, MetaLR 0.04, MetaSVM -1.00
- P13L (p.Pro13Leu), rs1035636941, ClinGen CA201692333, ClinVar RCV002905245, ClinVar RCV005047342, MetaLR 0.05, MetaSVM -1.01, Uncertain significance, Inborn genetic diseases; Autosomal recessive hypophosphatemic bone disease
- P13S (p.Pro13Ser), NCI-TCGA Cosmic COSV1007, cosmic curated COSV10074, MetaLR 0.04, MetaSVM -0.98, Variant assessed as somatic; moderate impact.
- P13P (p.Pro13Pro), rs144208635, gnomAD 9-137231741-C-G, CADD 0.15
- T14A (p.Thr14Ala), TOPMed rs992543951, gnomAD rs992543951, MetaLR 0.05, MetaSVM -1.01
- T14N (p.Thr14Asn), TOPMed rs1410537698, gnomAD rs1410537698, MetaLR 0.05, MetaSVM -1.06
- T14T (p.Thr14Thr), rs764319812, gnomAD 9-137231744-T-A, CADD 3.34
- L15V (p.Leu15Val), NCI-TCGA Cosmic COSV6318, cosmic curated COSV63187, MetaLR 0.13, MetaSVM -1.02, Variant assessed as somatic; moderate impact.
- L15M (p.Leu15Met), gnomAD 9-137231745-C-A, MetaLR 0.14, MetaSVM -1.03
- D16R (p.Asp16Arg), gnomAD 9-137231746-TGGAC, CADD 24.00
- D16E (p.Asp16Glu), gnomAD 9-137231750-C-A, MetaLR 0.03, MetaSVM -1.01
- D16D (p.Asp16Asp), rs752084146, gnomAD 9-137231750-C-T, CADD 1.62
- A17S (p.Ala17Ser), ExAC rs757872964, TOPMed rs757872964, gnomAD rs757872964, MetaLR 0.04, MetaSVM -0.99
- A17T (p.Ala17Thr), rs757872964, NCI-TCGA Cosmic COSV1007, cosmic curated COSV10074, ExAC rs757872964, MetaLR 0.03, MetaSVM -0.99, Uncertain significance, not provided
- A17V (p.Ala17Val), rs750770872, ExAC rs750770872, gnomAD rs750770872, MetaLR 0.05, MetaSVM -1.03, Variant assessed as somatic; moderate impact.
- A17A (p.Ala17Ala), gnomAD 9-137231753-G-C, CADD 0.38
- V18A (p.Val18Ala), ESP rs371595930, ExAC rs371595930, gnomAD rs371595930, MetaLR 0.04, MetaSVM -1.00
- V18F (p.Val18Phe), TOPMed rs1836229313
- V18I (p.Val18Ile), NCI-TCGA Cosmic COSV1007, cosmic curated COSV10074, MetaLR 0.03, MetaSVM -1.00, Variant assessed as somatic; moderate impact.
- D19G (p.Asp19Gly), ExAC rs753533178, TOPMed rs753533178, gnomAD rs753533178, MetaLR 0.03, MetaSVM -1.00
- D19N (p.Asp19Asn), gnomAD 9-137231757-G-A, MetaLR 0.05, MetaSVM -1.01
- D19A (p.Asp19Ala), gnomAD 9-137231758-A-C, MetaLR 0.04, MetaSVM -0.98
- D19D (p.Asp19Asp), gnomAD 9-137231759-C-T, CADD 2.33
- L20L (p.Leu20Leu), rs754465747, gnomAD 9-137231762-A-C, CADD 6.14
- V21A (p.Val21Ala), ExAC rs778419484, TOPMed rs778419484, gnomAD rs778419484, MetaLR 0.05, MetaSVM -1.00
- V21V (p.Val21Val), gnomAD 9-137231765-G-C, CADD 2.91
- E22G (p.Glu22Gly), Ensembl rs2131401558, MetaLR 0.04, MetaSVM -1.01
- E22K (p.Glu22Lys), rs146559846, ClinGen CA201692409, cosmic curated COSV63186, ClinVar RCV001339779, MetaLR 0.03, MetaSVM -1.06, Uncertain significance, not specified; not provided; Autosomal recessive hypophosphatemic bone disease
- E22E (p.Glu22Glu), gnomAD 9-137231768-A-G, CADD 4.33
- K23R (p.Lys23Arg), rs748039656, ClinGen CA5364181, ClinVar RCV003381268, ExAC rs748039656, MetaLR 0.02, MetaSVM -0.97, Likely benign, Inborn genetic diseases
- K23N (p.Lys23Asn), gnomAD 9-137231771-G-C, MetaLR 0.03, MetaSVM -1.01
- T24D (p.Thr24Asp), gnomAD 9-137231766-G-GA, CADD 23.90
- L25E (p.Leu25Glu), rs756418351, gnomAD 9-137231772-ACT-A, CADD 16.30
- L25L (p.Leu25Leu), rs1489283687, gnomAD 9-137231775-C-T, CADD 4.51
- R26K (p.Arg26Lys), TOPMed rs1206280444, gnomAD rs1206280444, MetaLR 0.04, MetaSVM -0.97
- R26M (p.Arg26Met), cosmic curated COSV63187, MetaLR 0.04, MetaSVM -1.05
- R26S (p.Arg26Ser), ExAC rs771909414, gnomAD rs771909414, MetaLR 0.04, MetaSVM -0.99
- R26T (p.Arg26Thr), TOPMed rs1206280444, gnomAD rs1206280444
- R26E (p.Arg26Glu), gnomAD 9-137231775-C-CT, CADD 22.40
- R26R (p.Arg26Arg), rs771909414, gnomAD 9-137231780-G-A, CADD 4.54
- N27D (p.Asn27Asp), Ensembl rs750540324, MetaLR 0.05, MetaSVM -0.99
- N27K (p.Asn27Lys), TOPMed rs1465244493, gnomAD rs1465244493, MetaLR 0.05, MetaSVM -0.99, Uncertain significance, Inborn genetic diseases; Autosomal recessive hypophosphatemic bone disease
- E28K (p.Glu28Lys), rs1190433400, TOPMed rs1190433400, gnomAD rs1190433400, MetaLR 0.03, MetaSVM -0.98, Variant assessed as somatic; moderate impact.
- E28V (p.Glu28Val), gnomAD 9-137231785-A-T, MetaLR 0.04, MetaSVM -1.05
- G29E (p.Gly29Glu), ExAC rs761269502, TOPMed rs761269502, gnomAD rs761269502, MetaLR 0.05, MetaSVM -1.07, Uncertain significance, Inborn genetic diseases; Autosomal recessive hypophosphatemic bone disease
- G29R (p.Gly29Arg), rs777567171, ClinGen CA5364185, ClinVar RCV000999299, ExAC rs777567171, MetaLR 0.10, MetaSVM -1.04, Uncertain significance, not provided
- G29W (p.Gly29Trp), gnomAD 9-137231787-G-T, MetaLR 0.12, MetaSVM -0.99
- G29G (p.Gly29Gly), gnomAD 9-137232073-G-C, CADD 1.68
- T30I (p.Thr30Ile), TOPMed rs1229665252, gnomAD rs1229665252, MetaLR 0.05, MetaSVM -1.00, Uncertain significance, Autosomal recessive hypophosphatemic bone disease
- T30N (p.Thr30Asn), TOPMed rs1229665252, gnomAD rs1229665252, MetaLR 0.04, MetaSVM -1.05, Uncertain significance
- T30T (p.Thr30Thr), gnomAD 9-137232076-C-T, CADD 3.85
- S31F (p.Ser31Phe), gnomAD rs1311518686, MetaLR 0.05, MetaSVM -1.08
- S31P (p.Ser31Pro), cosmic curated COSV63188, MetaLR 0.05, MetaSVM -1.03
- S32R (p.Ser32Arg), ExAC rs754208327, gnomAD rs754208327, MetaLR 0.07, MetaSVM -1.00, Uncertain significance, Inborn genetic diseases
- S32T (p.Ser32Thr), TOPMed rs1836253138, MetaLR 0.06, MetaSVM -1.06
- S32N (p.Ser32Asn), gnomAD 9-137232081-G-A, MetaLR 0.08, MetaSVM -1.04
- A34T (p.Ala34Thr), gnomAD rs746590268, MetaLR 0.05, MetaSVM -1.00, Uncertain significance, Autosomal recessive hypophosphatemic bone disease
- A34V (p.Ala34Val), TOPMed rs1284104939, gnomAD rs1284104939, MetaLR 0.06, MetaSVM -1.01
- P35L (p.Pro35Leu), TOPMed rs1326448994
- P35S (p.Pro35Ser), TOPMed rs1227263210
- P35T (p.Pro35Thr), NCI-TCGA Cosmic COSV6318, cosmic curated COSV63186, MetaLR 0.05, MetaSVM -1.02, Variant assessed as somatic; moderate impact.
- P35R (p.Pro35Arg), gnomAD 9-137232089-CCA-C, CADD 21.40
- P35P (p.Pro35Pro), rs1481963563, gnomAD 9-137232091-A-C, CADD 2.22
- V36V (p.Val36Val), gnomAD 9-137232094-C-G, CADD 2.56
- L37* (p.Leu37Ter), Ensembl rs1405145847, CADD 33.00
- L37S (p.Leu37Ser), Ensembl rs1405145847, MetaLR 0.12, MetaSVM -1.03
- L37L (p.Leu37Leu), rs1836254258, gnomAD 9-137232097-G-A, CADD 4.32
- E38G (p.Glu38Gly), cosmic curated COSV63187, MetaLR 0.07, MetaSVM -1.05, Uncertain significance, not specified
- E38E (p.Glu38Glu), rs1181248664, gnomAD 9-137232100-G-A, CADD 0.58
- E39K (p.Glu39Lys), rs759132724, NCI-TCGA Cosmic COSV6318, cosmic curated COSV63187, ExAC rs759132724, MetaLR 0.06, MetaSVM -1.06, Variant assessed as somatic; moderate impact.
- E39E (p.Glu39Glu), gnomAD 9-137232103-A-G, CADD 1.04
- G40E (p.Gly40Glu), cosmic curated COSV63187, MetaLR 0.03, MetaSVM -1.07
- G40R (p.Gly40Arg), gnomAD rs1278663821, MetaLR 0.06, MetaSVM -1.04, Uncertain significance, Autosomal recessive hypophosphatemic bone disease
- D41E (p.Asp41Glu), TOPMed rs1179016195, gnomAD rs1179016195, MetaLR 0.02, MetaSVM -0.99
- D41N (p.Asp41Asn), gnomAD rs1473081223, MetaLR 0.06, MetaSVM -1.02
- D41D (p.Asp41Asp), rs1179016195, gnomAD 9-137232109-C-T, CADD 2.99
- T42A (p.Thr42Ala), TOPMed rs1836255218, MetaLR 0.04, MetaSVM -0.99, Uncertain significance, Inborn genetic diseases
- T42I (p.Thr42Ile), cosmic curated COSV10526, MetaLR 0.04, MetaSVM -1.00
- T42R (p.Thr42Arg), rs1262519524, cosmic curated COSV10969, TOPMed rs1262519524, gnomAD rs1262519524, MetaLR 0.04, MetaSVM -1.02, Variant assessed as somatic; moderate impact.
- D43A (p.Asp43Ala), Ensembl rs1588841111
- D43E (p.Asp43Glu), TOPMed rs1005865796, gnomAD rs1005865796, MetaLR 0.07, MetaSVM -1.02, Likely benign
- D43N (p.Asp43Asn), cosmic curated COSV10466, MetaLR 0.11, MetaSVM -0.93
- D43H (p.Asp43His), gnomAD 9-137232113-G-C, MetaLR 0.18, MetaSVM -0.62
- P44F (p.Pro44Phe), cosmic curated COSV10526, MetaLR 0.32, MetaSVM -0.11
- P44L (p.Pro44Leu), gnomAD rs1423175467, MetaLR 0.32, MetaSVM -0.36
- P44S (p.Pro44Ser), TOPMed rs1836255839, MetaLR 0.32, MetaSVM -0.11, Uncertain significance, Inborn genetic diseases
- P44P (p.Pro44Pro), rs1158314165, gnomAD 9-137232118-C-T, CADD 8.54
- W45* (p.Trp45Ter), ExAC rs764856747, gnomAD rs764856747, CADD 42.00
- T46I (p.Thr46Ile), 1000Genomes rs752413019, ExAC rs752413019, gnomAD rs752413019, MetaLR 0.04, MetaSVM -1.05
- T46N (p.Thr46Asn), 1000Genomes rs752413019, ExAC rs752413019, gnomAD rs752413019
- T46P (p.Thr46Pro), Ensembl rs1588841131, MetaLR 0.04, MetaSVM -1.05
- T46T (p.Thr46Thr), gnomAD 9-137232124-C-T, CADD 8.33
- L47H (p.Leu47His), rs757815865, ClinGen CA5364218, ClinVar RCV001881897, ClinVar RCV002482713, MetaLR 0.15, MetaSVM -0.91, Uncertain significance, not provided; Autosomal recessive hypophosphatemic bone disease
- L47L (p.Leu47Leu), gnomAD 9-137232127-C-A, CADD 6.91
- P48A (p.Pro48Ala), rs1016356685, ClinGen CA375725784, ClinVar RCV004459185, gnomAD rs1016356685, MetaLR 0.06, MetaSVM -1.05, Uncertain significance, Inborn genetic diseases
- P48H (p.Pro48His), cosmic curated COSV10890
- P48S (p.Pro48Ser), gnomAD rs1016356685, MetaLR 0.05, MetaSVM -1.06, Uncertain significance
- P48L (p.Pro48Leu), rs1564415555, gnomAD 9-137232126-TC-T, CADD 23.00
- P48P (p.Pro48Pro), rs964624499, gnomAD 9-137232130-T-C, CADD 9.38
- Q49* (p.Gln49Ter), rs2131403056, ClinGen CA375725817, NCI-TCGA Cosmic COSV6318, cosmic curated COSV63187, CADD 36.00, Pathogenic
- Q49R (p.Gln49Arg), gnomAD 9-137232132-A-G, MetaLR 0.05, MetaSVM -1.06
- L50V (p.Leu50Val), ExAC rs763707162, gnomAD rs763707162, MetaLR 0.10, MetaSVM -0.72
- L50L (p.Leu50Leu), rs751402893, gnomAD 9-137232136-G-A, CADD 6.88
- K51N (p.Lys51Asn), NCI-TCGA TCGA novel, MetaLR 0.09, MetaSVM -1.00, Variant assessed as somatic; moderate impact.
- K51K (p.Lys51Lys), rs757247707, gnomAD 9-137232139-G-A, CADD 10.10
- D52E (p.Asp52Glu), cosmic curated COSV63186, ExAC rs781064068, TOPMed rs781064068, gnomAD rs781064068, MetaLR 0.07, MetaSVM -1.02
- D52N (p.Asp52Asn), cosmic curated COSV63186, MetaLR 0.07, MetaSVM -1.03
- D52H (p.Asp52His), gnomAD 9-137232140-G-C, MetaLR 0.10, MetaSVM -1.01
- D52D (p.Asp52Asp), rs781064068, gnomAD 9-137232142-C-T, CADD 7.74
- T53I (p.Thr53Ile), NCI-TCGA TCGA novel, TOPMed rs1668191303, MetaLR 0.09, MetaSVM -0.96, Variant assessed as somatic; moderate impact.
- T53K (p.Thr53Lys), gnomAD 9-137232144-C-A, MetaLR 0.08, MetaSVM -1.04
- S54I (p.Ser54Ile), cosmic curated COSV63187, MetaLR 0.06, MetaSVM -1.04
- S54N (p.Ser54Asn), ExAC rs756026661, TOPMed rs756026661, gnomAD rs756026661, MetaLR 0.06, MetaSVM -1.03
- S54R (p.Ser54Arg), ExAC rs779250807, gnomAD rs779250807, MetaLR 0.05, MetaSVM -1.05
- S54S (p.Ser54Ser), rs779250807, gnomAD 9-137232148-C-T, CADD 8.49
- Q55P (p.Gln55Pro), gnomAD 9-137232150-A-C, MetaLR 0.03, MetaSVM -1.03
- Q55Q (p.Gln55Gln), rs1460397719, gnomAD 9-137232151-G-A, CADD 6.66
- P56H (p.Pro56His), gnomAD 9-137232153-C-A, MetaLR 0.05, MetaSVM -1.03
- P56L (p.Pro56Leu), gnomAD 9-137232153-C-T, MetaLR 0.05, MetaSVM -1.04
- P56P (p.Pro56Pro), rs140180447, gnomAD 9-137232154-C-A, CADD 8.65
- W57G (p.Trp57Gly), Ensembl rs1588841231, NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- W57S (p.Trp57Ser), TOPMed rs1836258523, MetaLR 0.11, MetaSVM -0.97
- W57R (p.Trp57Arg), gnomAD 9-137232155-T-C, MetaLR 0.11, MetaSVM -0.97
- W57* (p.Trp57Ter), gnomAD 9-137232157-G-A, CADD 38.00
- K58Q (p.Lys58Gln), TOPMed rs1240637297, gnomAD rs1240637297, MetaLR 0.07, MetaSVM -1.06
- K58K (p.Lys58Lys), gnomAD 9-137232160-A-G, CADD 22.50
- E59A (p.Glu59Ala), ExAC rs761399770, TOPMed rs761399770, gnomAD rs761399770, MetaLR 0.09, MetaSVM -1.06
- E59D (p.Glu59Asp), 1000Genomes rs531529369, ExAC rs531529369, TOPMed rs531529369, gnomAD rs531529369, MetaLR 0.05, MetaSVM -1.05
- E59K (p.Glu59Lys), cosmic curated COSV63186, TOPMed rs1188666081, MetaLR 0.11, MetaSVM -0.88
- E59V (p.Glu59Val), ExAC rs761399770, TOPMed rs761399770, gnomAD rs761399770, MetaLR 0.09, MetaSVM -1.06
- E59S (p.Glu59Ser), gnomAD 9-137232157-GA-G, CADD 24.40
- E59G (p.Glu59Gly), gnomAD 9-137232575-A-G, MetaLR 0.09, MetaSVM -0.99
- E59E (p.Glu59Glu), rs531529369, gnomAD 9-137232576-G-A, CADD 9.24
- L60F (p.Leu60Phe), gnomAD rs1234145400, MetaLR 0.10, MetaSVM -1.01, Uncertain significance, Inborn genetic diseases
- L60R (p.Leu60Arg), Ensembl rs1388314265, MetaLR 0.05, MetaSVM -1.08
- p.Leu60 Leu66del, rs749421435, gnomAD 9-137232575-AGCTC, CADD 16.10
- L60I (p.Leu60Ile), gnomAD 9-137232577-C-A, MetaLR 0.06, MetaSVM -1.03
- L60L (p.Leu60Leu), gnomAD 9-137232579-C-A, CADD 3.79
- R61C (p.Arg61Cys), rs750340368, ClinGen CA5364260, cosmic curated COSV10074, ClinVar RCV003718088, MetaLR 0.02, MetaSVM -1.00, Uncertain significance, not provided
- R61H (p.Arg61His), 1000Genomes rs548021746, ExAC rs548021746, TOPMed rs548021746, gnomAD rs548021746, MetaLR 0.03, MetaSVM -1.06, Uncertain significance, not provided
- R61P (p.Arg61Pro), 1000Genomes rs548021746, ExAC rs548021746, TOPMed rs548021746, gnomAD rs548021746, MetaLR 0.03, MetaSVM -1.01, Uncertain significance, Autosomal recessive hypophosphatemic bone disease
- R61A (p.Arg61Ala), rs1473192539, gnomAD 9-137232578-TC-T, CADD 22.60
- R61R (p.Arg61Arg), rs766590721, gnomAD 9-137232582-C-G, CADD 1.12
- V62E (p.Val62Glu), Ensembl rs1030903618, MetaLR 0.04, MetaSVM -1.02
- V62M (p.Val62Met), rs754789761, ClinGen CA5364264, NCI-TCGA Cosmic COSV1007, cosmic curated COSV10074, MetaLR 0.03, MetaSVM -1.03, Uncertain significance, Inborn genetic diseases; not provided
- p.Val62 Ala63insCysVal, gnomAD 9-137232580-C-CGC, CADD 8.84
- V62A (p.Val62Ala), gnomAD 9-137232584-T-C, MetaLR 0.04, MetaSVM -1.00
- V62G (p.Val62Gly), gnomAD 9-137232584-T-G, MetaLR 0.04, MetaSVM -1.00
- V62V (p.Val62Val), gnomAD 9-137232585-G-T, CADD 1.83
- A63V (p.Ala63Val), TOPMed rs1204965503, MetaLR 0.05, MetaSVM -1.06
- A63A (p.Ala63Ala), rs370472204, gnomAD 9-137232588-C-T, CADD 0.77
- G64D (p.Gly64Asp), cosmic curated COSV10074, MetaLR 0.06, MetaSVM -1.06
- G64S (p.Gly64Ser), ESP rs143930538, ExAC rs143930538, TOPMed rs143930538, gnomAD rs143930538, MetaLR 0.03, MetaSVM -1.03, Uncertain significance, Inborn genetic diseases
- R65G (p.Arg65Gly), TOPMed rs1836287619, MetaLR 0.07, MetaSVM -1.01
Public SLC34A3 analysis runs
- SLC34A3 analysis run — SLC34A3 (1,218 variants) — completed 2026-08-19